Business

[HSBC HSBC]The share price of HSBC in London has risen by nearly 10%. Vaccine News Is Good For Global Banking Stocks-Hong Kong Economic Times-Live News Channel-Current Finance-Stock Market

[ad_1] Research and development of the new coronary pneumonia vaccine is progressing well and the vaccines developed by Pfizer (USA: PFE) and BioNTech (USA: BNTX) are effective. Traditional economic stocks are gaining momentum, global banking stocks have risen, and the London HSBC HSBC share price (00005) has risen more than …

Read More »

"Good luck … Fighting Bitcoin, Fighting Biden!" – JoinD

[ad_1] “Thank goodness … fight Bitcoin, fight Biden!”JoinD Bitcoin rebounded in one day …Coin leader JPMorgan “Grayscale Bitcoin Trust Outperforms Gold ETF”Coindesk Korea Presentation of PayPal’s virtual payment, led by two pizzas worth 150 billion BitcoinsEvery next day Bitcoin soaring with “Biden Election” .. Why?Coin leader View full content on …

Read More »

[Futures su azioni USA]Pfizer’s new corona vaccine is effective. Dow futures surpassed 1,500 points and approached 30,000 points (continuously updated) -Hong Kong Economic Times-News Channel-Market Finance-Stock Market-Hong Kong Economic Times-News

[ad_1] [Futures su azioni USA]Pfizer’s new corona vaccine worksHong Kong Economic Times-News Global equity markets are constantly updated | Wufei Vaccine reports good news, Dow Jones futures of US stocks rose more than 1500 pointsTaiwan Apple Daily Bai Deng wins 3 of the major US stock index futures opening over …

Read More »

Dow’s Future Up Nearly 1,600 Points, Pfizer’s Vaccine Trial Has Significant Results: Radio Hong Kong

[ad_1] Dow Futures Up Nearly 1,600 Points, And Pfizer’s Vaccine Trial Has Significant ResultsRadio Hong Kong [Futures su azioni USA]Pfizer’s new crown vaccine is effective, Dow futures have surpassed 1,500 points and the price of gold has fallen below 1900 (continuously updated) -Hong Kong Economic Times-Real Time News Channel-Market Finance-Stock …

Read More »

Markets rise, Dow futures add more than 1,400 points after upbeat vaccine data, Biden win

[ad_1] GlobeNewswire Cellectar reports its third quarter 2020 financial results and provides a company update FLORHAM PARK, NJ, November 9, 2020 (GLOBE NEWSWIRE) – Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late stage clinical biopharmaceutical company focused on the discovery, development and commercialization of cancer treatment drugs, announced today the financial …

Read More »